Novo Nordisk receives FDA approval for FlexTouch® in the US
1 November 2013 | By Novo Nordisk
FlexTouch® is the latest innovation in prefilled insulin delivery systems from Novo Nordisk...
List view / Grid view
News
Novo Nordisk increased operating profit by 10% in the first nine months of 2013
31 October 2013 | By Novo Nordisk
Sales growth of 8% driven by Victoza®, Levemir® og NovoRapid®...
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
"Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience..."
New Marketing Authorisation Application submitted to EMA for Ibrutinib for the treatment of two forms of blood cancer
30 October 2013 | By Johnson & Johnson
“The EMA Marketing Authorisation Application is an important milestone in the development of ibrutinib...”
Teva announces departure of President and CEO
30 October 2013 | By Teva Pharmaceutical Industries Ltd
Dr. Jeremy Levin will step down as President and Chief Executive Officer...
Abbott’s MitraClip® treatment demonstrates positive results for patients with degenerative mitral regurgitation at prohibitive risk for surgery
30 October 2013 | By Abbott
The MitraClip device provides physicians with a breakthrough treatment option for patients suffering from MR...
AstraZeneca advances MedImmune’s benralizumab to Phase III in severe asthma
30 October 2013 | By AstraZeneca
The goal of CALIMA is to determine whether benralizumab reduces the number of exacerbations in patients with severe asthma that remains uncontrolled...
Tecan’s AC Extraction Plate™ provides a unique sample preparation tool for LC-MS
29 October 2013 | By kdm communications
Tecan’s newly launched AC Extraction Plate is a revolutionary, automation-friendly solution designed to streamline sample preparation...
New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs
29 October 2013 | By GlaxoSmithKline
GSK and BMGF will invest a combined $1.8 million in early stage research into vaccine thermostability...
Merck announces presentation of interim data from phase 1B study of MK-3475, investigational anti-PD-1 immunotherapy
29 October 2013 | By Merck
“We are encouraged by these initial responses in NSCLC patients..."
New data show Striverdi® (olodaterol)* Respimat® improves exercise tolerance in patients with moderate to very severe COPD
29 October 2013 | By Boehringer Ingelheim
“Exercise is an essential component of COPD management..."
Howie Mandel challenges people to learn the fibs and facts about atrial fibrillation and its associated increased stroke risk
28 October 2013 | By Bristol-Myers Squibb
“Fibs or Facts” educational program launches today to help raise up to $25,000 for National Stroke Association...
Promising phase IIb data on Clazakizumab in patients with moderate-to-severe rheumatoid arthritis to be presented
28 October 2013 | By Bristol-Myers Squibb Company
Clazakizumab is a humanized anti-IL-6 monoclonal antibody directed against the IL-6 cytokine rather than the receptor...
Global Lung Cancer Coalition to identify patient challenges and improve support strategies in partnership with Boehringer Ingelheim
28 October 2013 | By Boehringer Ingelheim
'Lung Cancer: We're Listening' will gather much needed feedback from individuals touched by lung cancer...
New two-year results show SIMPONI® ARIA™ (GOLIMUMAB) for infusion inhibited radiographic progression in patients with active rheumatoid arthritis
28 October 2013 | By Johnson & Johnson
Nearly 70 percent of patients receiving SIMPONI ARIA at two years demonstrated ACR 20 response...
